Sun et al. found that upregulation of NEAT1 was positively associated with the expression levels of miR-140 in liver tissues of C57 NAFLD mice and FFA-treated HepG2 cells, both responsible for NAFLD progression by inactivating AMPK/SREBP-1 signaling pathway. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.